Physician profile
Arlene E Hudson
NPI 1760594428
$946.83
in general payments reported to CMS, 2019-2025
10 companies · $73.52 in 2025
The $73.52 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.80 · 2020: $46.79 · 2021: $208 · 2022: $264 · 2023: $168 · 2024: $139 · 2025: $73.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $438.78 | 2019-2024 | Cabenuva, Dovato, Apretude |
| Janssen Products, LP | $144.99 | 2021-2022 | |
| Abbvie INC. | $89.56 | 2022-2025 | |
| Gilead Sciences, INC. | $87.42 | 2023-2024 | |
| Janssen Biotech, INC. | $48.17 | 2021-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $42.05 | 2023 | Pifeltro, Delstrigo, Dificid |
| Exact Sciences Corporation | $33.46 | 2025 | The Cologuard Plus Collection Kit |
| Theratechnologies INC. | $30.55 | 2020 | |
| Astellas Pharma US INC | $16.24 | 2020 | |
| Glaxosmithkline, LLC. | $15.61 | 2023 | Arexvy, Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.